CFD 属于复杂的高风险金融工具,其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作,以及是否能够接受高额亏损的风险。

Scan to Download iOS&Android APP

交易 AcelRx - ACRX CFD

0.6968
0%
  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 0.0244
多头隔夜费

Long position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.024068%
空头隔夜费

Short position overnight fee


Margin. Your investment $1,000.00
隔夜费用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
0.001846%
隔夜费时间 21:00 (UTC)
最小交易量 0.01
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

关键数据
前收盘价* 0.6869
开盘价* 0.6469
1 年变化* 115.63%
日范围* 0.6389 - 0.6869
52 周范围 0.16-0.95
平均交易量(10 天) 589.82K
平均交易量(3 个月) 46.02M
市值 31.41M
市盈率 0.74
流通股 147.33M
收入 2.88M
EPS 0.29
股息(收益率 %) N/A
贝塔 0.45
下一个财报发布日期 Nov 14, 2022

所有数据都是由Refinitiv提供的, 除了标有星号的数据, 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平倉 Change Change (%) 開倉 High Low
Mar 24, 2023 0.6869 0.0001 0.01% 0.6868 0.6968 0.6519
Mar 23, 2023 0.7068 -0.0099 -1.38% 0.7167 0.7230 0.6639
Mar 22, 2023 0.7208 0.0569 8.57% 0.6639 0.8763 0.6639
Mar 21, 2023 0.6819 0.0867 14.57% 0.5952 0.6851 0.5683
Mar 20, 2023 0.5872 -0.0597 -9.23% 0.6469 0.6469 0.5472
Mar 17, 2023 0.6469 -0.0409 -5.95% 0.6878 0.7068 0.6369
Mar 16, 2023 0.6868 0.0004 0.06% 0.6864 0.7118 0.6371
Mar 15, 2023 0.7068 -0.1126 -13.74% 0.8194 0.8194 0.6069
Mar 14, 2023 0.8648 -0.3106 -26.43% 1.1754 1.2252 0.8494
Mar 13, 2023 1.0757 -0.0398 -3.57% 1.1155 1.1654 1.0557
Mar 10, 2023 1.1554 -0.0100 -0.86% 1.1654 1.1854 1.0955
Mar 9, 2023 1.1455 0.0001 0.01% 1.1454 1.1754 1.1055
Mar 8, 2023 1.1654 -0.0498 -4.10% 1.2152 1.2252 1.1454
Mar 7, 2023 1.1953 -0.0798 -6.26% 1.2751 1.2851 1.1653
Mar 6, 2023 1.2751 -0.0299 -2.29% 1.3050 1.3149 1.2351
Mar 3, 2023 1.2851 0.0100 0.78% 1.2751 1.2950 1.2551
Mar 2, 2023 1.2751 -0.0299 -2.29% 1.3050 1.3249 1.2451
Mar 1, 2023 1.2950 -0.0997 -7.15% 1.3947 1.4147 1.2950
Feb 28, 2023 1.3847 0.0099 0.72% 1.3748 1.4047 1.3548
Feb 27, 2023 1.3249 -0.0598 -4.32% 1.3847 1.3848 1.3249

AcelRx Events

時間(協調世界時) (UTC) 國家 事件
No events scheduled
查看所有活動
  • 年度
  • 每季度
2021 2020 2019 2018 2017
总收入 2.818 5.416 2.289 2.151 7.995
收入 2.818 5.416 2.289 2.151 7.995
收入成本,共计 3.753 6.032 6.806 3.976 10.659
毛利 -0.935 -0.616 -4.517 -1.825 -2.664
总营业费用 38.783 46.379 56.494 37.878 46.677
销售/一般/行政费用,总计 30.935 36.33 45.027 20.765 16.609
研究与开发 4.095 4.017 4.661 13.137 19.409
异常费用(收入) 0
营业收入 -35.965 -40.963 -54.205 -35.727 -38.682
利息收入(费用),非经营净值 -2.167 -2.722 -0.369 -1.079 -2.806
其他,净值 3.038 3.31 1.337 -10.341 -10.721
税前净收入 -35.094 -40.375 -53.237 -47.147 -52.209
税后净收入 -35.099 -40.379 -53.24 -47.149 -17.405
未计算非常项目前的净收益 -35.099 -40.379 -53.24 -47.149 -17.405
净收入 -35.099 -40.379 -53.24 -47.149 -51.508
普通股股东可获收益 (不含非经常性项目) -35.099 -40.379 -53.24 -47.149 -17.405
普通股股东可获收益 (含非經常性項目) -35.099 -40.379 -53.24 -47.149 -51.508
摊薄净收入 -35.099 -40.379 -53.24 -47.149 -51.508
摊薄后加权平均股 119.86 85.257 79.1843 58.4086 46.8835
扣除特别项目的每股摊薄盈利 -0.29283 -0.47362 -0.67236 -0.80723 -0.37124
每股正常摊薄盈利 -0.29387 -0.47362 -0.67236 -0.80723 -0.37124
非常规项目总计 0 -34.103
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
总收入 0.442 0.002 1.862 0.443 0.511
收入 0.442 0.002 1.862 0.443 0.511
收入成本,共计 0.784 1.234 0.439 1.04 1.04
毛利 -0.342 -1.232 1.423 -0.597 -0.529
总营业费用 9.437 8.177 10.495 10.458 9.653
销售/一般/行政费用,总计 7.338 5.957 8.64 8.694 7.644
研究与开发 1.315 0.986 1.416 0.724 0.969
营业收入 -8.995 -8.175 -8.633 -10.015 -9.142
利息收入(费用),非经营净值 -0.352 -0.435 -0.506 -0.63 -0.596
其他,净值 0.673 0.693 0.764 0.799 0.782
税前净收入 -8.674 -7.917 -8.375 -9.846 -8.956
税后净收入 -8.674 -7.917 -8.375 -9.851 -8.956
未计算非常项目前的净收益 -8.674 -7.917 -8.375 -9.851 -8.956
净收入 -8.674 -7.917 -8.375 -9.851 -8.956
普通股股东可获收益 (不含非经常性项目) -8.674 -7.917 -8.375 -9.851 -8.956
普通股股东可获收益 (含非經常性項目) -8.674 -7.917 -8.375 -9.851 -8.956
摊薄净收入 -8.674 -7.917 -8.375 -9.851 -8.956
摊薄后加权平均股 145.624 127.774 119.224 119.12 113.257
扣除特别项目的每股摊薄盈利 -0.05956 -0.06196 -0.07025 -0.0827 -0.07908
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常摊薄盈利 -0.05956 -0.06196 -0.07025 -0.08089 -0.08369
  • 年度
  • 每季度
2021 2020 2019 2018 2017
流动资产总额 55.489 46.83 71.688 107.994 63.413
现金和短期投资 51.63 42.886 66.137 105.715 60.469
现金等价物 12.663 27.274 14.684 87.975 52.902
短期投资 38.967 15.612 51.453 17.74 7.567
应收账款总额,净额 0.16 0.635 0.52 0.401 1.533
Accounts Receivable - Trade, Net 0.16 0.635 0.432 0.049 1.533
Total Inventory 1.111 1.626 3.295 0.854 0.956
Prepaid Expenses 2.588 1.683 1.736 1.024 0.455
Total Assets 77.893 66.295 91.356 120.533 75.552
Property/Plant/Equipment, Total - Net 20.23 18.809 18.48 11.483 11.051
Property/Plant/Equipment, Total - Gross 31.016 29.398 28.032 20.427 19.489
Accumulated Depreciation, Total -10.786 -10.589 -9.552 -8.944 -8.438
Other Long Term Assets, Total 2.174 0.656 0.925 0.705 0.385
Total Current Liabilities 18.509 17.635 13.611 15.928 13.66
Accounts Payable 2.121 2.737 1.72 2.07 1.424
Accrued Expenses 7.506 6.008 6.498 4.54 3.543
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 8.796 8.841 4.982 9.003 8.331
Other Current Liabilities, Total 0.086 0.049 0.411 0.315 0.362
Total Liabilities 113.786 122.045 132.774 116.28 112.061
Total Long Term Debt 5.007 13.14 20.517 3.38 11.369
Long Term Debt 5.007 13.14 20.517 3.38 11.369
Other Liabilities, Total 90.27 91.27 98.646 96.972 87.032
Total Equity -35.893 -55.75 -41.418 4.253 -36.509
Common Stock 0.137 0.098 0.079 0.078 0.051
Additional Paid-In Capital 437.554 382.637 356.609 349.194 261.31
Retained Earnings (Accumulated Deficit) -473.584 -438.485 -398.106 -345.019 -297.87
Other Equity, Total 0
Total Liabilities & Shareholders’ Equity 77.893 66.295 91.356 120.533 75.552
Total Common Shares Outstanding 136.82 98.812 79.5731 78.7579 50.8992
Note Receivable - Long Term 0.263 0.351 0.703
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流动资产总额 42.811 55.489 51.753 58.97 71.315
现金和短期投资 39.349 51.63 48.699 55.325 67.345
现金等价物 21.822 12.663 13.271 26.327 34.363
短期投资 17.527 38.967 35.428 28.998 32.982
应收账款总额,净额 0.184 0.16 0.153 0.104 0.658
Accounts Receivable - Trade, Net 0.184 0.16 0.153 0.104 0.658
Total Inventory 1.045 1.111 1.556 1.363 1.419
Prepaid Expenses 2.233 2.588 1.345 2.178 1.893
Total Assets 71.971 77.893 72.263 79.586 87.347
Property/Plant/Equipment, Total - Net 20.08 20.23 20.229 20.546 15.962
Other Long Term Assets, Total 0.261 2.174 0.281 0.07 0.07
Total Current Liabilities 17.033 18.509 17.07 15.188 15.544
Accounts Payable 2.715 2.121 2.228 1.941 3.235
Accrued Expenses 5.505 7.592 6.062 4.483 3.528
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 8.813 8.796 8.78 8.764 8.781
Other Current Liabilities, Total 0
Total Liabilities 110.244 113.786 115.284 115.575 114.659
Total Long Term Debt 3.041 5.007 6.952 9.374 11.265
Long Term Debt 3.041 5.007 6.952 9.374 11.265
Other Liabilities, Total 90.17 90.27 91.262 91.013 87.85
Total Equity -38.273 -35.893 -43.021 -35.989 -27.312
Common Stock 0.147 0.137 0.119 0.119 0.118
Additional Paid-In Capital 443.838 437.554 422.527 421.184 420.011
Retained Earnings (Accumulated Deficit) -482.258 -473.584 -465.667 -457.292 -447.441
Total Liabilities & Shareholders’ Equity 71.971 77.893 72.263 79.586 87.347
Total Common Shares Outstanding 147.109 136.82 119.317 119.18 119.103
Intangibles, Net 8.819
  • 年度
  • 每季度
2021 2020 2019 2018 2017
净收入/起跑线 -35.099 -40.379 -53.24 -47.149 -51.508
经营活动产生的现金 -30.002 -38.505 -51.18 -29.075 -29.765
经营活动产生的现金 1.973 1.853 1.668 0.575 1.744
非现金物品 2.921 2.309 4.298 15.632 16.3
Cash Taxes Paid 0.005 -0.347 -0.35 0.002 0.002
已付现金利息 1.595 2.269 1.712 1.667 2.043
营运资金的变化 0.203 -2.288 -3.906 1.867 3.699
投资活动产生的现金 -26.123 34.139 -36.563 -10.877 -9.97
资本支出 -1.827 -1.855 -3.47 -0.819 -2.405
其他投资现金流量项目,总计 -24.296 35.994 -33.093 -10.058 -7.565
融资活动产生的现金 41.514 16.956 14.452 75.025 12.327
融资现金流项目 5.313 -0.086 -9.054 0 -0.204
股票的发行(报废),净额 45.034 21.709 1.976 82.743 16.045
债务的发行(退还),净额 -8.833 -4.667 21.53 -7.718 -3.514
现金净变化 -14.611 12.59 -73.291 35.073 -27.408
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -8.674 -35.099 -27.182 -18.807 -8.956
Cash From Operating Activities -8.934 -30.002 -21.998 -18.055 -9.708
Cash From Operating Activities 0.42 1.973 1.512 1.029 0.45
Non-Cash Items 0.246 2.921 1.75 0.966 0.03
Changes in Working Capital -0.926 0.203 1.922 -1.243 -1.232
Cash From Investing Activities 20.176 -26.123 -21.684 -15.032 -17.425
Capital Expenditures -0.089 -1.827 -1.799 -1.615 -0.024
Other Investing Cash Flow Items, Total 20.265 -24.296 -19.885 -13.417 -17.401
Cash From Financing Activities -2.083 41.514 29.679 32.14 34.222
Financing Cash Flow Items -0.058 5.313 -0.249 -0.249 -0.249
Issuance (Retirement) of Stock, Net 0.058 45.034 36.678 36.556 36.554
Issuance (Retirement) of Debt, Net -2.083 -8.833 -6.75 -4.167 -2.083
Net Change in Cash 9.159 -14.611 -14.003 -0.947 7.089

为什么选择 Capital.com?让我们的数字来说话。

Capital.com Group

500K+

交易者

92K+

每月活跃客户

$53M+

每月投资额

$30M+

每月提取金额

交易計算器

如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。

貿易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模(槓桿 x 投資):
開倉

平倉

做空 做多

AcelRx Company profile

关于 AcelRx Pharmaceuticals Inc

AcelRx Pharmaceuticals, Inc.是一家专业制药公司。 该公司专注于开发和商业化用于医疗监管环境的疗法。 其产品和候选产品组合包括舒芬太尼舌下含服产品和候选产品、预灌封注射器候选产品和甲磺酸纳法莫司特候选产品。 其舒芬太尼舌下含服产品包括DSUVIA、DZUVEO和Zalviso,主要用于在医疗监督下治疗中度至重度急性疼痛。 其预充式注射器候选产品包括麻黄素和苯肾素。 其甲磺酸萘莫司他候选产品包括Niyad,这是一种用于注射到体外循环的区域性抗凝剂,以及LTX-608,这是一种用于抗病毒治疗COVID、急性呼吸窘迫综合症(ARDS)、播散性血管内凝血(DIC)和急性胰腺炎的萘莫司他制剂。

Industry: Bio Therapeutic Drugs

25821 Industrial Boulevard
Suite 400
94545

收入报表

  • Annual
  • Quarterly

人们也观看

Gold

1,957.93 Price
-1.080% 1D Chg, %
多头隔夜费 -0.0180%
空头隔夜费 0.0097%
隔夜费时间 21:00 (UTC)
价差 0.30

XRP/USD

0.46 Price
+4.270% 1D Chg, %
多头隔夜费 -0.0753%
空头隔夜费 0.0069%
隔夜费时间 21:00 (UTC)
价差 0.00442

Oil - Crude

71.78 Price
+3.260% 1D Chg, %
多头隔夜费 -0.0192%
空头隔夜费 -0.0027%
隔夜费时间 21:00 (UTC)
价差 0.03

US100

12,667.40 Price
-0.860% 1D Chg, %
多头隔夜费 -0.0241%
空头隔夜费 0.0018%
隔夜费时间 21:00 (UTC)
价差 1.8

还在找一位您可以信任的经纪商吗?

加入成为全球500,000万多名交易者的一份子,选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易